CryoTherapeutics SA

CryoTherapeutics SA is at the forefront of medical equipment manufacturing, dedicated to developing innovative solutions for critical cardiac conditions. Specializing in cryotherapy, CryoTherapeutics has engineered a novel, minimally invasive, catheter-based cryotherapy system (CTS) designed to treat coronary vulnerable plaque (VP), a leading cause of myocardial infarction (MI). The primary address of CryoTherapeutics SA is Rue de Bruxelles 174 E40 Business Park, Awans, 4340, BE.

CryoTherapeutics' cutting-edge technology delivers localized cryotherapy to vulnerable plaques, cooling them to precise temperatures to reduce inflammation and increase fibrous cap thickness. This innovative approach aims to stabilize vulnerable plaques, significantly reducing the risk of rupture and preventing future myocardial infarctions. By avoiding foreign materials and minimizing reliance on long-term medical therapy, CryoTherapeutics SA offers a unique solution in interventional cardiology.

CryoTherapeutics SA is committed to advancing cardiac care through pioneering technology and a focus on patient outcomes. Our dedicated team continues to drive innovation in cryotherapy, with the goal of improving the lives of individuals at risk of heart attack. We invite the manager of CryoTherapeutics SA to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.